Chronic kidney disease of non-traditional causes and proposed risk factors prevalence in hemodialysis patients from southwest Guatemala

dyspareunia, 0.93% vaginal bleeding). Among mothers with BV, 8.5% reported any current vaginal symptoms (2.6% malodorous discharge, 0.74% grey discharge, 4.4% pruritus, 2.9% dyspareunia, 0.74% vaginal bleeding). Among mothers without AVF, 7.7% reported any symptoms (1.6% malodorous discharge, 0.54% grey discharge, 5.2% pruritus, 2.5% dyspareunia, 0.52% vaginal bleeding). There was no significant difference in the frequency of any vaginal symptoms among infected and uninfected women (c2(1)1⁄4 0.97, p1⁄40.33). Using clinical signs as a screening diagnostic tool would have only detected 9.0% of the women with AVF (sensitivity 9.0%, specificity 92.3%, PPV 17.5%, NPV 84.8%). Interpretation: The prevalence of AVF is high and the majority of mothers are asymptomatic. There is no significant difference in the prevalence of vaginal symptoms between mothers with and without AVF infection. A symptom-based screening approach is ineffective in identifying AVF and BV. Alternate and feasible diagnostic methods are needed to screen for AVF and BV in resource-limited settings. Funding: National Institute of Health. Abstract #: 01NCD018